|
Volume 9 Issue 4
|
|
Comment |
|
|
Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin
Graham A Colditz Breast Cancer Research 2007, 9:108 (26 July 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Mammary stem cell number as a determinate of breast cancer risk
Christophe Ginestier, Max S Wicha Breast Cancer Research 2007, 9:109 (31 July 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage
Heather L LaMarca, Jeffrey M Rosen Breast Cancer Research 2007, 9:304 (20 July 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Amping up estrogen receptors in breast cancer
Amy M Fowler, Elaine T Alarid Breast Cancer Research 2007, 9:305 (16 August 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
Review |
|
|
Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer
Louise R Howe Breast Cancer Research 2007, 9:210 (16 July 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice
Raffaele Calogero, Francesca Cordero, Guido Forni, Federica Cavallo Breast Cancer Research 2007, 9:211 (10 August 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
David G DeNardo, Lisa M Coussens Breast Cancer Research 2007, 9:212 (15 August 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
Research |
|
|
Accuracy of computed tomography perfusion in assessing metastatic involvement of enlarged axillary lymph nodes in patients with breast cancer
Yun Liu, Massimo Bellomi, Giovanna Gatti, Xuejun Ping Breast Cancer Research 2007, 9:R40 (5 July 2007)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Computed tomography perfusion gives information on vascularisation of lymph nodes, and may be an effective tool for studying enlarged axillary lymph nodes in breast cancer patients.
|
|
|
Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells
Takeshi Sugimoto, Chandra Bartholomeusz, Ana M Tari, Naoto T Ueno Breast Cancer Research 2007, 9:R41 (5 July 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Expression of truncated Int6/eIF3e in mammary alveolar epithelium leads to persistent hyperplasia and tumorigenesis
David L Mack, Corinne A Boulanger, Robert Callahan, Gilbert H Smith Breast Cancer Research 2007, 9:R42 (12 July 2007)
Abstract | Full text | PDF | PubMed
|
|
|
The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells
Youqi Han, Serban San-Marina, Lin Yang, Haytham Khoury, Mark D Minden Breast Cancer Research 2007, 9:R43 (16 July 2007)
Abstract | Full text | PDF | PubMed
|
|
|
The effect of psychosocial factors on breast cancer outcome: a systematic review
Matthew E Falagas, Effie A Zarkadoulia, Eleni N Ioannidou, George Peppas, Christos Christodoulou, Petros I Rafailidis Breast Cancer Research 2007, 9:R44 (17 July 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Application of the multicellular tumour spheroid model to screen PET tracers for analysis of early response of chemotherapy in breast cancer
Azita Monazzam, Raymond Josephsson, Carl Blomqvist, Jörgen Carlsson, Bengt Långström, Mats Bergström Breast Cancer Research 2007, 9:R45 (22 July 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Breast cancer is a promising target for vaccination using cancer-testis antigens known to elicit immune responses
Mark Taylor, Louise M Bolton, Peter Johnson, Tim Elliott, Nick Murray Breast Cancer Research 2007, 9:R46 (24 July 2007)
Abstract | Full text | PDF | PubMed
|
|
|
The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis
Albert JM Yee, Margarete Akens, Bing L Yang, Joel Finkelstein, Peng-Sheng Zheng, Zhaoqiong Deng, Burton Yang Breast Cancer Research 2007, 9:R47 (27 July 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Analysis of the cellular centrosome in fine-needle aspirations of the breast
Hui-qin Guo, Meixia Gao, Jinfang Ma, Ting Xiao, Lin-lin Zhao, Yanning Gao, Qin-jing Pan Breast Cancer Research 2007, 9:R48 (29 July 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Characterization of a negative transcriptional element in the BRCA1 promoter
Gwen MacDonald, Melissa Stramwasser, Christopher R Mueller Breast Cancer Research 2007, 9:R49 (30 July 2007)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
A repressor element identified in the BRCA1 promoter brings a new level of complexity to the regulation of BRCA1 expression, which is known to be involved in the development of sporadic breast cancer.
|
|
|
Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
Iain R Hutcheson, Janice M Knowlden, Steve E Hiscox, Denise Barrow, Julia MW Gee, John F Robertson, Ian O Ellis, Robert I Nicholson Breast Cancer Research 2007, 9:R50 (8 August 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Heregulin beta1 can overcome the inhibitory effects of gefitinib on cell growth and invasion in tamoxifen-resistant cells, which may have implications on the effectiveness of anti-EGFR therapies in breast cancer.
|
|
|
GnRH and LHR gene variants predict adverse outcome in premenopausal breast cancer patients
Djura Piersma, Axel PN Themmen, Maxime P Look, Jan GM Klijn, John A Foekens, André G Uitterlinden, Huibert AP Pols, Els MJJ Berns Breast Cancer Research 2007, 9:R51 (10 August 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women
Paul E Goss, Peyman Hadji, Milayna Subar, Paula Abreu, Torben Thomsen, Jose Banke-Bochita Breast Cancer Research 2007, 9:R52 (10 August 2007)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Exemestane - but not letrozole or anastrozole - increased serum levels of a known bone formation marker, which may correlate with a decreased risk of osteoporosis compared with nonsteroidal aromatase inhibitors.
|
|
|
No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort
Martijn Verheus, Petra HM Peeters, Paulus AH van Noord, Yvonne T van der Schouw, Diederick E Grobbee, Carla H van Gils Breast Cancer Research 2007, 9:R53 (13 August 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
BCoR-L1 variation and breast cancer
Felicity Lose, Jeremy Arnold, David B Young, Carolyn J Brown, Graham J Mann, Gulietta M Pupo, The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Kum Khanna, Georgia Chenevix-Trench, Amanda B Spurdle Breast Cancer Research 2007, 9:R54 (16 August 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients
Javier Silva, Vanesa García, José M García, Cristina Peña, Gemma Domínguez, Raquel Díaz, Yolanda Lorenzo, Alicia Hurtado, Antonio Sánchez, Félix Bonilla Breast Cancer Research 2007, 9:R55 (21 August 2007)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Levels of Bmi-1 expression may be a surrogate marker
of poor prognosis in breast cancer and may become clinically useful as non-invasive diagnostic markers.
|
|
|
1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice
Yunpeng Su, Kathryn Vanderlaag, Courtney Ireland, Janelle Ortiz, Henry Grage, Stephen Safe, Arthur E Frankel Breast Cancer Research 2007, 9:R56 (31 August 2007)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
A new peroxisome proliferator-activated receptor (PPAR)-gamma agonist shows anti-proliferative effects on basal-like breast cancer cells and dramatic tumour growth inhibition in animal models at safe doses.
|
|
|
Correlation between CpG methylation profiles and hormone receptor status in breast cancers
Weiwei Feng, Lanlan Shen, Sijin Wen, Daniel G Rosen, Jaroslav Jelinek, Xin Hu, Shaoyi Huan, Miao Huang, Jinsong Liu, Aysegul A Sahin, Kelly K Hunt, Robert C Bast, Yu Shen, Jean-Pierre J Issa, Yinhua Yu Breast Cancer Research 2007, 9:R57 (31 August 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
